Devin Pierce

Simple tips for technical leaders who want to start communicating more effectively: - Avoid Jargon - Practice active listening - Give frequent feedback - Share a clear vision - Overcommunicate Yes, it’s this easy to improve. #tech #LeadershipDevelopment #LeadershipMatters

Medicine hasn't ignored women's health. It's reduced it to abortion and the pill. I got to be in a room last week where scientists who've spent careers being ignored for talking about anything else — hormones, fertility, metabolism, bone health — finally got to be taken seriously. Researchers presenting alongside policymakers and patient advocates. No green rooms, no hierarchy, no performance. It was unusual. And honestly kind of moving. @KatyTalento wrote a great piece about it, and about the twenty years of medical gaslighting that preceded it.

We asked the FDA to say no to Pharma. I do not mean we asked politely. I mean we built a regulatory agency whose entire function is to tell the most profitable industry in the world that it cannot do what it wants. 🧵

We asked the FDA to say no to Pharma. I do not mean we asked politely. I mean we built a regulatory agency whose entire function is to tell the most profitable industry in the world that it cannot do what it wants. We staffed it. We funded it. We gave it authority. We call this public health infrastructure. The name is the thing we did. We did not build anything to protect it when Pharma pushed back. Pharma pushed back. This was not a surprise. This was not a betrayal. A company told no by a regulator will attempt to remove the regulator. This is not corruption. This is a business model. Corruption implies deviation from the norm. This is the norm. Pharma funds the media. Not as a side arrangement. As the operating budget. Pharmaceutical advertising is the financial infrastructure of American health journalism. The news about the FDA is brought to you by the companies the FDA regulates. This is disclosed in the fine print. The fine print is the point. When the FDA says no, the media covers the FDA. The coverage is not about the regulation. The coverage is about the regulator. This is more efficient. A regulation can be debated on the merits. A regulator can be destroyed on character. One of those outcomes is reversible. Vinay Prasad’s job is to tell Pharma no. The media’s job is to make that impossible. The Wall Street Journal ran sexual harassment allegations against him. The allegations didn’t exist. The original story ran everywhere. The correction came nineteen days later. Quietly. On page six. Nineteen days is not a correction. Nineteen days is a strategy. Prasad is leaving. The strategy worked. Marty Makary’s job is to tell Pharma no. The media is coming for Marty Makary. Tracy Beth Høeg’s job is to tell Pharma no. The media is coming for Tracy Beth Høeg. The playbook does not change. The strategy works. We watch this happen. We call it bias. We write about it. We post about it. We describe the mechanism in great detail to people who already understand the mechanism. Pharma is not threatened by people who understand what Pharma is doing. Understanding the mechanism is not the same as breaking it. Two things break the mechanism. The mechanism is not broken. Leadership cover breaks it. The President. The White House. Every health agency head. The entire administration standing behind the regulator when the regulator says no. Not a statement. Not a spokesperson. A wall. FDA leaders who know they will not be abandoned can hold the line. FDA leaders who are not sure must manage their exposure instead. They will do as much good as they can without being shown the door. This is a rational response to an irrational situation. Public outcry moves leadership. It must be loud enough to be unavoidable. Unavoidable means abandoning the regulator costs more than protecting the industry. Unavoidable means silence is no longer politically safe. Neither eliminates the attacks. The attacks don’t need to be eliminated. The attacks need to be survivable. Public outcry makes them so. You now have a choice. You can know this, and know that you know it, and watch what happens next. The show is well-produced. The outrage cycles are timed. The corrections run on page six. Nineteen days later, if you’re lucky. There is a version of this where you live a perfectly comfortable life and the FDA never regulates anything that matters and you never have to do anything about it. Or you can get loud enough that protecting Pharma costs more than it’s worth. Those are the only two options. Pick one.

@jeffreytucker I watched patients die alone holding iPads. We can never forget.

@HCLibertyLab @KatyTalento 😊😊😊

Find women who celebrate your wins and call you on your bullshit. Anything less is a waste of time.

What to do with @US_FDA? Options: 1: Don't regulate. Shut it down. 2: Don't regulate, but pretend. Run it with morally corrupt losers in white coats who serve pharma. 3: Regulate drugs. Hire competent people & let them do their jobs. The media wants option 2.

HHS & FDA are finally writing policy that supports women. Never thought I'd see the day. Loving every minute.

Do we want @US_FDA to 'rubberstamp' or 'do science,' or does it just depend on who's asking? Top regulator was just destroyed for insisting on safety/efficacy data while haters celebrated his demise. Now this? What do we want FDA to do? Or is it just about opposition?

What we think boys need: structure, supervision, curriculum, therapy. What they actually need: dangerous tools, men to imitate, failure nobody rescues them from, and enough time in the sun that the cobwebs clear. These are not the same thing. Link in comments to new article.

Great non technical essay on the roots of Vinay’s exit : patients with terrible diseases desperate for hope. Even better : Maps a way forward from this debacle that doesn’t involve burning everything down.

READ:

What I love about this essay is how skillfully TR captures the point of view of the patient with rare disease. And… Why it’s so important for them that new therapies pass an evidentiary bar Indeed the patients w rare disease should be most sad about Vinay’s departure

My latest piece just published. Every word was painful, but some things must be written. signalandnoise.online/p/the-war-on-e…

Excellent piece on the departure of Vinay Prasad from the FDA.

This is well worth your time if you want to understand what the White House needs to do in order to ensure MAHA as a movement wins the midterms. The policy and action is already there in spades; it’s the social media and communications leviathan that needs to improve.

@ESPNCleveland The answer is yes

Should the Browns build around Shedeur Sanders as their QB1 in 2026? The Browns have 2 1st round picks in the 2026 NFL Draft.

You cannot simultaneously demand rigorous evidence AND attack people for beginning a rigorous investigation.

@AppleHelix The only thing that matters to the American public and to the parents of the kids that died is if it’s true or not. If it benefits @VPrasadMDMPH and he’s doing the right thing, isn’t that a good thing? Why would anything other than truth matter?

@realdocspeaks @HCLibertyLab Great article and great to see some willingness to change policy as new data/information presents itself. Better late than never!